Among the breast cancer subtypes, TNBC is the most aggressive, has a poor prognosis and a high risk of recurrence and metastasis (4–6), and complicates targeted therapies in patients due to the absence of hormonal receptors (ER, PR, HER2) (6). The gene discussed is ERBB2; the disease is breast cancer.